KSA
Mubasher TV
 Contact Us Advertising   العربية
KSA
TDWL Closed
23 March 05:49 PM

Sector News

Photo Archive
19 March 11:50 AM LVP Pharma nearly doubles shareholding in Rameda for EGP 1.1bn
Cairo - Mubasher: LVP Pharma raised its ownership in Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) to 23.15% from 12% at a value of EGP 1.13 billion, according to a bourse filing. The firm acquired 223 million …
Companies Investments
Photo Archive
3 March 01:34 PM Ibnsina Pharma’s consolidated profits jump to EGP 952m in 2025
Cairo - Mubasher: Ibnsina Pharma recorded consolidated net profits after tax worth EGP 951.98 million in 2025, which reflected a year-on-year (YoY) surge from EGP 614.56 million. The earnings per share (EPS) grew to EGP 0.76 in January-December …
Financial Results
Rameda’s stock regains momentum after correction
2 March 01:26 PM Rameda’s stock regains momentum after correction
Cairo - Mubasher: The stock of Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) has successfully regained its upward momentum following a sharp correction after reaching its all-time high near EGP 4.81 in February …
Stock Evaluations
Photo Archive
22 February 01:12 PM LVP PHARMA ups stake in Rameda for EGP 215m
Cairo - Mubasher: Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) stated that LVP PHARMA raised its stake to 11.76% from 9.22%. LVP PHARMA purchased 51.52 million shares at an average price of EGP 4.17 per share, …
Corporate Actions
Photo Archive
9 February 08:01 PM Nozha International Hospital’s net profits cross EGP 174m in 2025
Cairo - Mubasher: Nozha International Hospital generated year-on-year (YoY) higher net profits after tax at EGP 174.19 million in 2025, compared with EGP 117.66 million. The earnings per share (EPS) grew to EGP 0.67 in the January-December 2025 …
Financial Results
Nozha International Hospital
9 February 04:32 PM Nozha International Hospital unveils EGP 58m capital increase, new asset details
Cairo - Mubasher: The board members of Nozha International Hospital approved raising its issued and paid-up capital by EGP 58 million to EGP 300 million from EGP 242 million through bonus shares. The capital increase will be financed from retained …
Companies Investments
EIPICO stock is poised to break out of historical peak – Analysis
5 February 03:23 PM EIPICO stock is poised to break out of historical peak – Analysis
Cairo – Mubasher: Technical movements signaled by Mubasher Trade Research indicate that the stock of the Egyptian International Pharmaceutical Industries Company (EIPICO) has continued its main upward trend, as it experienced a sharp correction …
Trading Activities
Photo Archive
3 February 06:08 PM Al Safwa Hospital’s equityholders greenlight EGP 40m capital raise
Cairo - Mubasher: The extraordinary general meeting (EGM) of Al Safwa Hospital approved increasing its issued and paid-up capital by EGP 40 million to EGP 81 million from EGP 41 million. The capital hike transaction will be carried out through the …
General Assembly
Photo Archive
1 February 12:05 PM El-Nile for Pharmaceuticals logs 155% leap in H1-25/26 net profits
Cairo - Mubasher: El-Nile Company for Pharmaceuticals and Chemical Industries generated EGP 170.07 million in net profits after tax during the first half (H1) of fiscal year (FY) 2025/2026. The results marked a 155.10% year-on-year (YoY) surge …
Financial Results
Photo Archive
26 January 12:11 PM EBRD grants EGP 1.3bn loan to Ibnsina Pharma for new warehouse
Cairo - Mubasher: The European Bank for Reconstruction and Development (EBRD) is extending an EGP 1.30 billion (EUR 23.10 million) loan to Ibnsina Pharma to finance green capital expenditure for a new warehouse and related long-term working …
Companies Investments
Rameda stock witnesses sideways range amid future upward opportunities
25 January 07:10 AM Rameda stock witnesses sideways range amid future upward opportunities – Analysis
Cairo – Mubasher: Technical movements signaled by Mubasher Trade Research indicate that the Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents’ (Rameda) stock has been moving within a volatile sideways trend since the beginning …
Stock Evaluations
Speed Medical’s stock reflects strong technical breakthrough
11 January 03:21 PM Speed Medical’s stock reflects strong technical breakthrough
Cairo – Mubasher: Technical analysis indicates that Speed Medical Company’s stock has seen a significant rise from June 2025 to December 2026. Indicators highlighted a marked improvement in buying momentum, with the price successfully breaking …
Stock Evaluations
EIPICO stock attracts buying power, tests resistance ahead of historic peak
28 December 2025 07:15 PM EIPICO stock attracts buying power, tests resistance ahead of historic peak
Cairo – Mubasher: The stock of Egyptian International Pharmaceutical Industries Company (EIPICO) is moving in a strong upward trajectory in the current period, as it is experiencing a sharp correction after reaching a historic peak at EGP 84 in …
Stock Evaluations
Photo Archive
8 December 2025 03:08 PM Macro Group’s EGP 570m capital increase nearly fully subscribed
Cairo - Mubasher: The rights issue of Macro Group Pharmaceuticals achieved 99% oversubscription during the period from 18 November until 3 December 2025. The capital increase process registered subscription in 2.82 billion new ordinary shares at a …
Corporate Actions
Photo Archive
3 December 2025 02:06 PM Minapharm’ consolidated net profits retreat to EGP 62m in 9M-25
Cairo - Mubasher: Minapharm Pharmaceuticals generated consolidated net profits after tax of EGP 61.81 million in the first nine months (9M) of 2025, lower year-on-year (YoY) than EGP 73.16 million. The basic and diluted earnings per share (EPS) …
Financial Results
Photo Archive
25 November 2025 03:47 PM Minapharm posts EGP 66.5m standalone net profits in 9M-25; sales hit EGP 2.8bn
Cairo - Mubasher: Minapharm Pharmaceuticals registered an annual surge in non-consolidated net profits after tax to EGP 66.56 million during the first nine months (9M) of 2025, versus EGP 17.13 million. The earnings per share (EPS) dropped to EGP …
Financial Results
Photo Archive
16 November 2025 02:45 PM GSK Egypt posts lower consolidated net profits at EGP 30m in 9M-25
Cairo - Mubasher: The consolidated net profits after tax of Glaxo SmithKline (GSK Egypt) reached EGP 30.21 million in the first nine months (9M) of 2025, marking a year-on-year (YoY) plunge from EGP 105.82 million. The earnings per share (EPS) …
Financial Results
Photo Archive
13 October 2025 05:17 PM Macro Group’s shareholders greenlight EGP 570m capital increase
Cairo - Mubasher: The extraordinary general meeting (EGM) of Macro Group approved increasing the issued capital by EGP 570.20 million to EGP 684.24 million from EGP 114.04 million The transaction will be financed in cash through a rights issue, …
Companies Investments
Photo Archive
23 September 2025 10:26 AM Premium Healthcare unveils EGP 1.5bn regional expansion plans
Cairo - Mubasher: The board of Premium Healthcare Group has approved an expansion plan valued at EGP 1.48 billion, including the establishment of four new companies in Egypt and Kuwait as part of its future strategy. The move will be financed …
Global Economy
Photo Archive
10 September 2025 09:13 AM Cleopatra Hospital obtains OGM’s nod for capital hike
Cairo - Mubasher: The ordinary general meeting (OGM) of Cleopatra Hospital Group has approved a capital increase to EGP 724.72 million from EGP 721.89 million. Shareholders agreed to raise the company’s issued share capital by EGP 2.83 million, …
Corporate Actions
Photo Archive
31 August 2025 05:18 PM Cleopatra Hospitals registers 42% surge in H1-25 consolidated net profits
Cairo - Mubasher: The consolidated net profits after tax of Cleopatra Hospitals Group hit EGP 521.54 million in the first half (H1) of 2025, marking a 42.22% hike from EGP 366.76 million in H1-24. The EGX-listed group posted EGP 3.38 billion in …
Financial Results
Photo Archive
14 August 2025 04:09 PM GSK Egypt’s consolidated net profits shrink to EGP 65m in H1-25
Cairo - Egypt: GlaxoSmithKline (GSK Egypt) generated lower consolidated net profits after tax at EGP 65.05 million as of 30 June 2025, compared to EGP 92.55 million in the year-ago period. The EGX-listed company achieved year-on-year (YoY) higher …
Financial Results
Photo Archive
13 July 2025 03:13 PM Rameda unveils capital hike to EGP 500m
Cairo – Mubasher: The extraordinary general meeting (EGM) of Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) approved a capital hike to EGP 500 million from EGP 377.74 million. The shareholders agreed to increase …
Companies Investments
Photo Archive
11 June 2025 03:26 PM Cleopatra Hospitals Group obtains regulatory nod for capital reduction
Cairo – Mubasher: Cleopatra Hospitals Group obtained the Financial Regulatory Authority’s (FRA) approval to reduce its capital to EGP 721.89 million from EGP 722.71 million. The group will cut its issued capital by EGP 824,288 through cancelling …
Corporate Actions
Photo Archive
26 May 2025 10:55 AM Cleopatra Hospitals Group sees higher consolidated profits at EGP 232m in Q1-25
Cairo – Mubasher: Cleopatra Hospitals Group generated EGP 232.28 million in consolidated net profit after tax during the first quarter (Q1) of 2025, an annual hike from EGP 204.62 million. Basic and diluted earnings per share (EPS) went up to EGP …
Financial Results